401 related articles for article (PubMed ID: 21515363)
1. Cdc42 in oncogenic transformation, invasion, and tumorigenesis.
Stengel K; Zheng Y
Cell Signal; 2011 Sep; 23(9):1415-23. PubMed ID: 21515363
[TBL] [Abstract][Full Text] [Related]
2. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
Boissier P; Huynh-Do U
Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
[TBL] [Abstract][Full Text] [Related]
3. Targeting Cdc42 in cancer.
Arias-Romero LE; Chernoff J
Expert Opin Ther Targets; 2013 Nov; 17(11):1263-73. PubMed ID: 23957315
[TBL] [Abstract][Full Text] [Related]
4. Influencing cellular transformation by modulating the rates of GTP hydrolysis by Cdc42.
Fidyk N; Wang JB; Cerione RA
Biochemistry; 2006 Jun; 45(25):7750-62. PubMed ID: 16784226
[TBL] [Abstract][Full Text] [Related]
5. BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study.
Makrodouli E; Oikonomou E; Koc M; Andera L; Sasazuki T; Shirasawa S; Pintzas A
Mol Cancer; 2011 Sep; 10():118. PubMed ID: 21943101
[TBL] [Abstract][Full Text] [Related]
6. Cellular signaling for activation of Rho GTPase Cdc42.
Sinha S; Yang W
Cell Signal; 2008 Nov; 20(11):1927-34. PubMed ID: 18558478
[TBL] [Abstract][Full Text] [Related]
7. Nm23-H1 modulates the activity of the guanine exchange factor Dbl-1.
Murakami M; Meneses PI; Knight JS; Lan K; Kaul R; Verma SC; Robertson ES
Int J Cancer; 2008 Aug; 123(3):500-10. PubMed ID: 18470881
[TBL] [Abstract][Full Text] [Related]
8. Constitutively active Cdc42 mutant confers growth disadvantage in cell transformation.
Vanni C; Ottaviano C; Guo F; Puppo M; Varesio L; Zheng Y; Eva A
Cell Cycle; 2005 Nov; 4(11):1675-82. PubMed ID: 16294011
[TBL] [Abstract][Full Text] [Related]
9. Antiapoptotic Cdc42 mutants are potent activators of cellular transformation.
Tu SS; Wu WJ; Yang W; Nolbant P; Hahn K; Cerione RA
Biochemistry; 2002 Oct; 41(41):12350-8. PubMed ID: 12369824
[TBL] [Abstract][Full Text] [Related]
10. Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers.
Aguilar BJ; Zhou H; Lu Q
Curr Med Chem; 2017; 24(32):3485-3507. PubMed ID: 28571533
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic Dbl, Cdc42, and p21-activated kinase form a ternary signaling intermediate through the minimum interactive domains.
Wang L; Zhu K; Zheng Y
Biochemistry; 2004 Nov; 43(46):14584-93. PubMed ID: 15544329
[TBL] [Abstract][Full Text] [Related]
12. A Rac/Cdc42-specific exchange factor, GEFT, induces cell proliferation, transformation, and migration.
Guo X; Stafford LJ; Bryan B; Xia C; Ma W; Wu X; Liu D; Songyang Z; Liu M
J Biol Chem; 2003 Apr; 278(15):13207-15. PubMed ID: 12547822
[TBL] [Abstract][Full Text] [Related]
13. Maintenance of CDC42 GDP-bound state by Rho-GDI inhibits MAP kinase activation by the exchange factor Ras-GRF. evidence for Ras-GRF function being inhibited by Cdc42-GDP but unaffected by CDC42-GTP.
Arozarena I; Matallanas D; Crespo P
J Biol Chem; 2001 Jun; 276(24):21878-84. PubMed ID: 11285260
[TBL] [Abstract][Full Text] [Related]
14. Epithelial junctions and Rho family GTPases: the zonular signalosome.
Citi S; Guerrera D; Spadaro D; Shah J
Small GTPases; 2014; 5(4):1-15. PubMed ID: 25483301
[TBL] [Abstract][Full Text] [Related]
15. The suppressor of metastasis Nm23-H1 interacts with the Cdc42 Rho family member and the pleckstrin homology domain of oncoprotein Dbl-1 to suppress cell migration.
Murakami M; Meneses PI; Lan K; Robertson ES
Cancer Biol Ther; 2008 May; 7(5):677-88. PubMed ID: 18728402
[TBL] [Abstract][Full Text] [Related]
16. Targeting Rac and Cdc42 GTPases in Cancer.
Maldonado MDM; Dharmawardhane S
Cancer Res; 2018 Jun; 78(12):3101-3111. PubMed ID: 29858187
[TBL] [Abstract][Full Text] [Related]
17. Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways.
Lim L; Manser E; Leung T; Hall C
Eur J Biochem; 1996 Dec; 242(2):171-85. PubMed ID: 8973630
[TBL] [Abstract][Full Text] [Related]
18. RasGRF suppresses Cdc42-mediated tumour cell movement, cytoskeletal dynamics and transformation.
Calvo F; Sanz-Moreno V; Agudo-Ibáñez L; Wallberg F; Sahai E; Marshall CJ; Crespo P
Nat Cell Biol; 2011 Jun; 13(7):819-26. PubMed ID: 21685891
[TBL] [Abstract][Full Text] [Related]
19. Cdc42 and Ras cooperate to mediate cellular transformation by intersectin-L.
Wang JB; Wu WJ; Cerione RA
J Biol Chem; 2005 Jun; 280(24):22883-91. PubMed ID: 15824104
[TBL] [Abstract][Full Text] [Related]
20. Effector proteins exert an important influence on the signaling-active state of the small GTPase Cdc42.
Phillips MJ; Calero G; Chan B; Ramachandran S; Cerione RA
J Biol Chem; 2008 May; 283(20):14153-64. PubMed ID: 18348980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
